Opportunity: Sartorius & Science Prize for Regenerative Medicine & Cell Therapy

The Sartorius & Science Prize for Regenerative Medicine & Cell Therapy is an annual prize geared toward researchers focused for an essay on basic or translational research that advances regenerative medicine and cell therapy.

Winners get $25,000 and publication in Science

Next application deadline: October 1, 2017




“Overcoming the Roadblocks to Cardiac Cell Therapy Using Tissue Engineering”

Report from the PCBC Cardiovascular Tissue Engineering Symposium, Birmingham, AL, March 2016

Link to full article:




Bioinformatics Committee Conference Call, August 23, 2017

NHLBI Progenitor Cell Biology Consortium (PCBC)

Bioinformatics Committee Conference Call

Wednesday, August 23, 2017, 3:00 PM - 4:00 PM (EDT)

(2 PM – 3 PM, CDT; 1 PM - 2 PM, MT; 12 Noon – 1 PM, PDT)

Conference dial-in number: 1-800-882-3610, enter passcode 5748013 followed by #

See attached meeting minutes and agenda below:

Postdoctoral Positions – iPS cells and muscle regeneration

Two postdoctoral researcher positions are available in the laboratory of Dr. Rita Perlingeiro at the Lillehei Heart Institute, University of Minnesota, to study skeletal muscle differentiation from pluripotent stem cells (Cell Stem Cell, 10:610, 2012; Nat. Comm. 4:1549, 2013; Cell Reports, 19:2867, 2017). One project is focused on gene editing of patient-specific LGMD2I iPS cells, and the other on the development and optimization of cGMP iPS-derived myogenic progenitors for clinical trial readiness.

“PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors” – Thomson Hub Site 02

Drs. Alessandro Magli, James Thomson, Rita Perlingeiro, and colleagues identify CD54, integrin a9b1, and SDC2 as surface markers that enable the purification of myogenic progenitors endowed with long-term regenerative potential. [27Jun2017 Cell Reports]

Link to full article:


Specification and Diversification of Pericytes and Smooth Muscle Cells from Mesenchymoangioblasts

Drs. Akhilesh Kumar, James Thomson, Igor Slukvin, and colleagues find that mesodermal pericytes and smooth muscle cells in human pluripotent stem cell cultures originate from a common endothelial and mesenchymal cell precursor, the mesenchymoangioblast. They show how different lineages of mural cells are specified from mesenchymoangioblasts and define stage- and lineage-specific markers for vasculogenic cells. [30May2017 Cell Reports]

Link to full article:

FOAs: Revision Applications for Regenerative Medicine Innovation Projects (RMIP): R43/R44; R41/R42; U54; UM1; UC4; U24; R01; R24; UM2; P50; P41; U01

FOAs: Revision Applications for Regenerative Medicine Innovation Projects (RMIP) [R43/R44; R41/R42; U54; UM1; UC4; U24; R01; R24; UM2; P50; P41; U01].

Cardiovascular Regenerative Medicine Symposium, September 27-28, 2017

The 2017 Cardiovascular Regenerative Medicine Symposium will take place September 27-28, 2017, at the National Institute of Health Campus in Bethesda, MD.

For more information:

PCBC Multiplexed in situ Hybridization Workshop (Materials and Recordings)

With the support of the NHLBI Progenitor Cell Biology Consortium (PCBC), Mark Krasnow, Tushar Desai, Pehr Harbury, and colleagues hosted a “PCBC Multiplexed in situ Hybridization Workshop” on March 22, 2017, at Stanford University.

“Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling” – Morrisey Hub Site 14

Drs. Katherine McCauley, Finn Hawkins, Darrell Kotton, and colleagues report that cyclical modulation of the canonical Wnt signaling pathway enables rapid directed differentiation of human iPSCs via an NKX2-1+ progenitor intermediate into functional proximal airway organoids. [30Mar2017 Cell Stem Cell]


Link to full article:




Copyright ©2013 NHLBI Progenitor Cell Biology Consortium.

University of Maryland School of Medicine logo

National Heart Blood and Lung Institute logo